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MAGNETIC NANO PARTICLES AS CONTRAST AGENTS FOR MR AND 
CT IMAGING 
SUMMARY 
Magnetic nanoparticles are increasingly used for clinical applications such as drug 
delivery, magnetic resonance imaging andmagnetic fluid hyperthermia. Due to their 
unique magnetic properties, excellent biocompatibility as well as multi-purpose 
biomedical potential(e.g., applications in cancer therapy and general drug delivery), 
superparamagnetic iron oxide nanoparticles(SPIONs) are attracting increasing 
attention in both pharmaceutical and industrial communities. A novel method of 
interstitial heating of tumours following direct injection of magneticnanoparticles has 
been evaluated in humans in recent clinical trials. Thermotherapy using magnetic 
nanoparticles is a new cancer therapy, in which iron oxidenanoparticles are directly 
injected into a tumor and subsequently heated in an alternatingmagnetic field. 
Nano particles and as specific form, metal based nano particles with Sr and Ba are 
produced in laboratory for using as in vitro use in MRI and CTI experiments. Metalic 
nano particles under magnetic field are increased in temperature and this property is 
used in MR imaging systems. We produced metal base nano particles in laboratory 
and placed our productions in magnetic field while detecting their temperature. Nano 
particles were mixed in agar gell (as blood medium) during placing in magnetic field. 
Increasing of tempearture was detected by inferared thermometer while subjecting to 
magnetic field. In an in vitro simulation, nano particles injected in a meat tissue and 
their MR and CT imageswere taken. Images showe our produced particles in a nice 
and effective contrast agent. In comparition with ordinary contrast agents, our nano 
particles are more effective in MR and CT imaging. 
Size of these nano particles are also changed with changing amount of solvent in 
solution. SEM images also showe different size nano particles with different solvent 
amount. During producing particles it was shown that heat anealing of nano particles 
reduce noises in X-Ray  
Usage of these nano particles as contrast and also treatment agent in cancer curing 
can decrease side effect of cancer treatment and increase hope to life for cancer 
patient in future. 
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MAGNETIC NANO PARTICULLERICONTRAST AGENT OLARAK MR 
VE CT DE GÖRÜNTÜLERI 
ÖZET 
Manyetik nanopartiküller giderek bu ilaç dağıtım, manyetik rezonans görüntüleme ve 
manyetik sıvı hipertermi gibi klinik uygulamalar için kullanılır. Kendilerine özgü 
manyetik özellikleri, mükemmel biyouyumluluk yanı sıra çok amaçlı biyomedikal 
potansiyeli (örneğin, kanser tedavisi ve genel ilaç dağıtım uygulamaları), 
Süperparamanyetik demir oksit nano (SPIONs) nedeniyle ilaç ve endüstriyel 
toplumların hem de artan bir ilgi çekmektedir. Manyetik nano partiküller doğrudan 
enjeksiyonu takiben tümörlerin interstisyel bir ısıtma yeni bir yöntem son klinik 
çalışmalarda insanlarda değerlendirilmiştir. Manyetik nano partiküller kullanılarak, 
termoterapi demir oksit nano-tanecikleri, bir doğrudan tümör içine enjekte edilir ve 
daha sonra, bir alternatif manyetik alan içinde ısıtıldı edildiği yeni bir kanser terapisi 
vardır. 
Nano partiküller ve özel bir biçimi olarak, Sr, Ba, metal bazlı nano parçacıklar MR 
ve CTI deneylerde in vitro kullanımı olarak kullanmak için laboratuarda 
üretilmektedir. Manyetik alan altında metalik nano parçacıklar ısı artar ve bu özellik 
MR görüntüleme sistemleri kullanılır. Biz laboratuvarda metal taban nano 
parçacıklar üretilen ve sıcaklık tespit ederken manyetik alan bizim yapımları 
yerleştirilir. Nano parçacıklar manyetik alan yerleştirme süresince agar jel (kan 
ortamı) içinde karıştırıldı. Manyetik alana maruz ise hararet değiştirme birimi artan 
inferared termometre tarafından tespit edildi. Bir in vitro simülasyonda, nano 
parçacıklar bir et dokusunda enjekte ve MR ve BT görüntüleri alındı. Görüntüler 
güzel ve etkili bir kontrast madde bizim üretilen parçacıklar showe. Sıradan kontrast 
madde ile comparition olarak, bizim nano parçacıklar MR ve BT görüntülemede 
daha etkilidir. 
Bu nano parçacıkların boyutu da çözelti içinde çözücü miktarının değiştirilmesi ile 
değiştirilir. SEM görüntüleri de farklı çözücü miktarı ile farklı bir boyut nano 
parçacıklar showe. Üreten parçacıklar sırasında nano parçacıklar ısı anealing önemli 
ölçüde, X-Ray saçılma sesler azaltmak olduğu gösterilmiştir. 
Kontrast ve kanser kür tedavi ajanı olarak bu nano parçacıklar kullanımı gelecekte 
kanser hastanın yaşam için umut kanser tedavisi ve artışın yan etkisi azaltabilir. 
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1- Introduction to cancer and conventional treatment methods 
1-1Cancer 
 Cancerisadiseasecharacterized bytheformationofabnormaltissue(neoplasm), 
achangeinthewaycellsproliferate anddifferentiate.  Ascancermetastasizes (spreads),it 
causes illness and eventually death. According torecent USA statistics, cancer  isthe 
second leading cause of death behind cardiovascular  disease, and  it is projected that 
cancerwill  become theleading causeofdeath  within afewyears.More than566,000 
deathsoccurasaresultofcancerandapproximately 1.4millionnewcasesarediagnosed 
yearly in the United States . 
1-2Conventional diagnose and treatment methods 
There has been an increasing need for the early diagnosing of cancer, prior to 
the detection of anatomic anomalies, in order to gain maximum therapeutic benefit. 
In early detection, in clinical diagnosis optical imaging is used to achieve 
simultaneously high spatial and temporal resolution in a rapid fashion.But it is 
difficult to visually find the locatation of these small lesions during clinical 
operation, since the cancer cells are not bio-luminescent. Furthermore, contrast 
agents are not specific to tumors, making the interpretation of the diagnosis results 
largely dependent on the experience of the physician. This will cause an uncertainty 
in providing conclusive diagnosis. 
Until now, the  main therapies are  surgery,  radiation therapy and  
chemotherapy. Localtreatments, radiation therapy andsurgery areused in 
nonemetastatic situations. In thecaseof  surgery, ifthe cancerisfound atanearly 
stage,itissuccessful .But,once cancerhasdevelopedtolocally advanced cancer or 
metastatic  cancer, chemotherapeutic  treatments using anti-cancer  drug areusedas 
themost powerful and reliable method .  Since anti-cancer drug cannot distinguish 
cancercellsfromnormal cells,limited successhasbeenobtainedintherapy 
ofsolidtumors(85%ofallcancers). Toimprove efficacy and  safetysubstantial efforts 
have beenmade todevelop  anew strategy forenhancing the drug delivery ofanti-
cancersfrombloodintothetumorsites. 
 
 
1-3Application of MRI and CT scan in conventional treatment methods 
 2 
1-3-1 Magnetic resonance imaging (MRI)  
MRIisoneofthemostcommonlyused diagnosticimagingtoolsbecauseitgives 
precise anatomical information and is quick andeasy to do [1].  Its function is based 
on the interaction 
betweenanexternalmagneticfieldandthenuclearspinangularmomentum ofNMR-active 
nuclei.  Theoverallspinoftheatom givesinformationonthepossiblenumberof 
orientations.   Forinstance,anucleuswithaspinof1/2(e.g.
1
Hnuclei)canhavetwo 
orientations: a positive spin of +1/2 and a negative spin of -1/2 which can be in 
random motion. Withoutamagneticfield,thesespins have equalenergybutwhen placed 
betweenthepolesofastrongmagnet,thenuclear spins adopt specificorientations(i.e. 
either parallelor anti-parallel)along theappliedmagneticfield[1]. 
finally,themagneticfield 
causestheenergylevelstosplitandeachlevelisdenotedwithamagneticquantum number 
(m).   Theparallelorientationhas slightlylowerenergythantheanti-parallelorientation 
thereforeitisslightlymorefavourable.   AccordingtoaBoltzmanndistribution,thehigher 
energy orientation has a slightly lower proportion of the nuclei population than the 
lower energyorientation. 
Theenergydifference(ΔE)betweenthesetwoorientationsdependson 
thestrengthoftheappliedfield(B0)[2]. Figure1Ashowestheconceptofenergylevel 
splitting of a nucleus. 
 
 
 
 
Figure1. 1:  A)ApplyingamagneticfieldsplitsthedegeneracyofthenucleusaccordingtoaBoltzmann distribution. Thelower energy 
statecontains slightly more nuclear spins than the higher energy state. The differenceinthetwoenergystatesisproportionaltoB
0
; 
B)TheCartesiancoordinatesystem isusedtodescribe nucleiprecession intermsofvectors.  Thenuclei process about themagnetic 
fieldB
0
. 
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Inside amagneticfield, individualprotonnucleiprecess aboutthemagneticfield. 
Theyaretiltedslightlyawayfrom theaxis ofthemagneticfield,buttherotation axis 
remainsparallelto B0(Figure 1B) . Thestrongerthe B0, thegreatertheenergydifference 
betweenthetwo spin statesand thereforea higher frequency (higher energy) radiation 
is requiredforaspin-fliptooccur.   Theprecessionfrequency isproportionalto the 
magnetic field strength and is expressed by Equation 1 whereυ0is the  Larmor 
frequencyinMHz,B0isthemagneticfieldstrengthinTesla(T)experiencedbytheprotonnucl
ei,andγis the gyromagnetic ratio ofthe nuclei (γ = 2.675 x 108s-1T-1for 1Hnuclei). 
                                   Equation 1 
Whentheorientednucleiareirradiatedwithradiofrequency(rf) pulsesattheLarmor 
frequency,theenergyisabsorbedbythenucleusandcausestheangleofprecessionto change 
.   For  example, for  a low  energy  (+1/2) spin  state,  absorption of  resonant 
radiationenergyflipstheorientation tothehigherenergystate. finally,thenucleinow exist 
in the excited state which has a finite lifetime; thus relaxation processes follow. 
Relaxationdoes not happen by emission of radiation because the probability 
of re- emitting photons at radiofrequencies is very low;hencenon-
radiativerelaxationprocesses takeplace[2]. Non-radiativerelaxationhappens 
byeitherspin-lattice(T1) orspin-spin(T2) relaxation. 
Vibratingandrotatingnucleiproduceamagneticfieldwhichisreferred toasthe latticefield. 
Someofthehigh-energynuclei willcontain vibrational/rotationalfrequenciesthat are 
equivalent to and in-phase with the Larmor frequency [2]. This energy match results 
the high-energynucleitospin-fliptothelow-energy state. 
Thesenucleiregaintheirequilibrium positionbyreturningtothelow-
energystateandtheexcessenergyis losttothelatticeinthe formofheat(T1process)[2]. 
Theamountoftimeitneedsfortheexcitedstatetoreturnto63%ofitsoriginalstateisdenotedT
1. T2relaxationhappensthroughtheexchangeofenergy between the two energy levels.  
It explains the interaction between neighboring nuclei which have the same 
vibrational/rotational frequencies .   Nuclei can exchange their quantum 
statesandthenucleusinthelow-energystatebecomesexcitedwhilethehigh- 
energynucleusrelaxestothelow-energystate. 
 4 
T2isthetotallossoftransversecoherencewhichincludesthe 
T2relaxationprocessasdescribedaboveandlossof transversecoherence 
duetoafluctuatinglocalmagneticfieldaroundeachprotonnucleiT1isthetimeit 
causesforthemagnetizationtoreturntoequilibriumalongthezaxiswhereasT2isthespoil of 
magnetization along the x and y axes to their equilibrium  states so that zero net 
macroscopic magnetization can be stored. 
InMRI,the magneticfieldismadespatiallydependentby applyinglinearmagnetic 
fieldgradients[1]. Agradientalongeachaxisofthecoordinatesystem isappliedtogain an 
image through slice selection, frequency encoding, and phase encoding[1, 3]. 
Protons, eitherinfatorwater,willresonateatauniquefrequencythatdependson 
theirexactposition within the gradient field. The obtained image is a frequency map 
of the protons with respect totheirpositionanddifferingmagneticfields[3].   
Pixelintensitydependsonthe numberofprotonscontainedwithinavoxel(volumeelement) 
with respect to theT1andT2relaxationtimes[1,3]. Gradientpulses produce less than 
1%of fielddistortion,so they cause relatively small perturbations to the main 
magnetic fieldB0. 
TheprotonT1relaxationtimeismeasuredbyaninversionrecovery(IR)pulse 
sequence that is shown in Figure 2 [4]. The IR sequence consists of two 
radiofrequency (rf)pulses. Thefirst180°pulsealongthe x-
axisflipsthemagnetizationalongthez-axisand isallowedtorecoverforaperiod τ. 
Themagnetizationreturnsto equilibrium alongthez-axis,during the recovery period. 
The valueof the magnetizationremainingafterthedelaytimeτ 
isthenmeasuredbyapplyinga90°pulsealongthey-axisfollowedbyacquisition.   The 
magnetizationalongthez-axismustbefullysavedtoitsequilibriumstatebeforerepeating 
the sequence with a newτ. 
 
 
 
Figure1.2:Theinversionrecoverypulse sequence is commonlyusedto measure theT
1
relaxation time. 
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τvariation cause aplotofintensityasafunctionofτ(inseconds)canbeobtained(Figure3A). 
Alinearrelationshipcanbeobtained fromwhichtheslopeprovidesthevalueof 
T1,(Figure3B)byintegratingtheexponential growthcurve(Figure3A). 
Theinversionrecoverysequence 
mustberepeatedforaseriesofτvaluesinordertofittheintensitydatatotheintegrated Bloch  
equation  (Equation  2)  that  describes  the  relationship  between  T1and  the  
magnetization. 
 
                  Equation 2 
 
A             B 
 
 
Figure1 .3:A)AnexponentialgrowthcurveformeasuringtheT1  relaxationtime[4]. Thisisobtainedby 
varyingτandisdescribedbyequation10; B)IntegrationofthecurveinAgivesalinearrelationshipfrom whichtheT1value can be 
extracted. 
 
Figure 1is the Carr-Purcell-Meiboom-Gill (CPMG)  sequence (a  spin  echo 
sequence) which is used to measure the proton T2relaxation time .   For MRI 
experiments, this sequence consisted of 96 echoes in total, therefore the 180° pulse 
was applied 96 times. 
 
 
 
Figure 1.4 :ACPMGsequencemeasuresT
2
[5]. Thedashedlineindicatestherepetitionofthe180°pulse foratotalof 96echoes. 
 
Thefirst90°pulseflipsthemagnetizationontothey-axisandoveraperiodofτ,the nuclear 
spins startto  precess in  the  xy  plane.   The 180y°  inverts onlythe sign of the 
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magnetizationvectornotthedirectionofprecession.  Aftera whileτ,thespins 
coincideandaspinechoresultsastheyprecessinoppositedirections. Afteraperiodofτ, 
the180y°pulseisgivedagaintodetectthespinecho. Thisprocesswasrepeated96times 
tomonitorthedecayofthespinechowithtime. Equation3showesanexponentialdecay 
relationshipbetweenT2andthemagnetization. ThevalueofT2is obtained from the slope. 
 
                             Equation3 
 
A               B 
 
 
Figure1.5 :A)AnexponentialdecayofaspinechomeasurestheT
2
valueforagiven numberofspinechoes 
accordingtoequation3;B)IntegrationofthedecaycurveinAprovidesalinearrelationshipfromwhichthe T
2
valuecan 
beobtainedfromtheslope. Atime of 2τaccounts for the total time between twoconsecutive 180° pulses. 
 
Theechotime(TE)isthetimefromtheexcitationpulseto theechosignalmaximum. TE 
determines the amount of T2weighting for spin-echo images. The repetition time 
(TR)is thetimebetweensuccessiveexcitationpulses. TRdeterminestheamountofT1  
weighting contributingtotheimagecontrast. 
TheT1inversiontime(orthedelaytime,τ)isthetime betweenthe180° and 90° pulses in the 
IR sequence. The specificvaluesoftheseparameters that were used in the MRI 
experimentsare explained in the method section. 
 
1-3-2 X-ray scattering and computed tomography (CT)  
CT provides information about theanatomical features of bones, tissues, and 
muscle. DifferentialattenuationoftheincidentX-rays causescontrastinCT. X-
raysareaform ofhigh-
energyelectromagneticradiationandhavewavelengthsfrom10to0.01nm. 
Whenacceleratedelectronsfromthecathodeof an X-ray tube interact with the 
atoms of an anode target ,theyareproduced. Intense heating of the cathode 
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filamentreleaseselectronsbythermionicemission. Electronsgatheratthesurfaceof the 
filament and results in a large build-up of negative charge . Appling a 
highvoltageacrossthecathodeandanodecause theelectronsaccelerateimmediately 
toward thepositiveanode. Eachelectronhasakineticenergy(inkeV)equaltotheapplied 
tube voltage . 
 
 
 
Figure1.6 :   Electrons1,2,and3collide,decelerate,andexperienceachangeintheirmomentumwiththe 
emissionofacontinuousenergyspectrum ofX-rayphotons. Electron4collideswithanelectronintheKshell oftheatom 
andproducescharacteristicradiation. Theenergyoftheincomingphotonmustbegreaterthanthe K-
shellelectronbindingenergytodisplace it. Anelectronina higher shellreplacesthevacantspot intheK shell and emitsX-rays that are 
characteristicof thatspecific atom . 
 
ForCT,theenergyrangeis120–140kV(50 –70keV)dependingontheexamination. 
Fast moving electrons rapidly decelerate upon colliding with the target nuclei at the 
anode (e.g. rhodium anode). Kinetic energy lost by theelectronsis convertedintoX-ray 
photons whichgenerateacontinuum ofX-rays(theBremsstrahlungspectrum). 
Closerinteractions withthenucleuscause 
greaterdecelerationofelectronsandresultsinhigherX-rayphoton energies.   
Theprobabilityofthisoccurrencedecreaseswithincreasingdistancefromthe nucleus. 
WhenanincidentphotondisplacesaK-shellelectron uponcollision,an 
electronfromahigherenergylevelfillsthevacantspot. Theelectronthatfillsthevacant 
spotemitsanX-raywithenergyequaltothedifferenceinthebindingenergiesofthe 
electronsinthehighershellandKshell,whichischaracteristicofthatspecificatom. Figure 
6illustratesthisconcept. Theenergyforthistransitionisveryhighbecauseitisbasedon 
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thedisplacementofanelectronfromtheclosestenergylevel(theKshell)tothenucleusof 
theatom.  AnX-rayspectrum usuallycontainssharpcharacteristicpeaksofmaximum 
energies (in keV) for specific L → K electron transitions (Figure 7A) .These peaks 
are characteristicbecauseeachelementhasdifferent electron binding energies. 
Figure7Bis exampleofanX-rayspectrum obtainedusingarhodium anodeandarhodium 
filterwhich cutsoffallX-raysgreaterthan23.22keV. Arhodium 
anodeandfilterwereusedwhen 
signalenhancementwithrespecttowaterwasmeasuredforNPs,Gd-DTPA,andiopramide 
at25,35,and45kVp. Acopperfilterwasused whentheexperimentwascarriedoutat49 
kVp. 
 
  
A B 
Figure1.7 :A)AnexampleofanX-rayenergyspectrumobtainedat80kVpillustratingtheBremsstrahlung 
spectrumandthecharacteristicradiationpeaks;B)ArhodiumfilterremovesallX-raysenergiesgreaterthan 23.22keV. 
Thecharacteristicenergypeaksofrhodiumappearat20.3and22.7keV. Themolybdenumpeaks are shownforcomparison purposes. 
 
Otherthanphotoelectricabsorptionasdescribedabove,X-rayemissioncanalso 
occurthroughpairproduction,Rayleighscattering,and Comptonscattering. Pair 
production is the displacement of an electron and generation of a positron. This can 
occur if theincidentX-rayphotonhasenergygreaterthan1.02MeV.   Anyexcessenergyis 
convertedintothekineticenergy ofbothparticulatesandissplit equally. Ionizationof the 
atomdoes not occur.  Such high-energy X-rays are more commonly used in PET; 
thus the probabilityofpairproductioninCTisverylow.   
Rayleighscatteringoccurswhenthe 
incidentphotonisdeflectedbyanelectronwithnolossofenergy. Theenergyofthe 
electronistemporarily increased and since it is not enough for complete removal, it 
returns to itsnormalenergystatebyemittinganX-ray 
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photonequaltotheinitialenergyincreaseand travelsinaslightlydifferentdirection 
.Thisscatteringeventhasvery lowprobabilityof 
occurringinsofttissuebecauseoflowatomicnumberelementsbeingpresent.   Compton 
scatteringoccurswhenanincidentX-rayphoton 
interactswithavalenceshellelectronwhich is not tightly bound to the nucleus . Energy 
of the incoming photon is much greater than thebindingenergyoftheelectron.   
Uponcollision,onlyapartofthephotonenergyis transferred to the electron. The photon 
continues to travel but with reduced energy and the electron is ejected from  its shell .   
Compton scattering dominates at higher X-ray energies. The probabilityof 
photoelectronabsorption occurring decreases as the incidentX- ray  photon  energy  
increases.   This  relationship  is  represented  by  Equation  4  where 
μphotoelectronis the X-ray attenuation factor andE is energy of the incident X-ray 
photon energy beam. 
 
Mphotoelectron α1/E
3
Equation 4 
 
Tissuesinthehumanbodycontainmostlylowatomicnumberelementstherefore they have 
low K-shell binding energies and less prominentcharacteristicX-rayproduction .  In 
order to image with greater contrast, the use of high atomic number elements such as 
iodine (I, Z=53) and Gd (Z=64) would be beneficial. The K-shell binding energies of 
I and Gd are 33.2 and 50.2 keV, respectively . The probability of 
photoelectricabsorption increases with increasing atomic number (Equation 5). 
µ photoelectron α Z 
3
                              Equation 5 
 
In  summary,  attenuation  of  X-rays  is  greater  when  working  with  higher  
atomic number  elements  and  lower  X-ray  energies.   However,  in  cases  where  
differentiation betweenfatandmuscleisnecessary,high-energyX-raysarerequired. 
Forsuchpurposes, theuseofGd-
basedcontrastagentsdesignedtoselectivelypartitionintooneofthetwo tissues would be 
highly advantageous. 
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Figure 1.8 :TheX-ray energy profile ofGdand I. Asuddenincrease inthe linear attenuationindicates the amount ofX-rayenergy 
requiredtodisplaceanelectronintheKshell ofthat specificatom forphotoelectric absorption to occur. 
 
Inorderto comparecontrastand testthepotentialofNPsasCTagents,X-ray 
scatteringexperimentswereperformedonPAA25-coatedGdF3/EuF3  NPs,Gd-
DTPA,and iopramide(IP)inwater. 
Toachievemaximalcontrast,imagingshouldbeperformedatX- ray energies where the 
linear attenuation is highest according to figure 8.A sudden increase 
intheattenuationofX-raysindicatestheincidentphoton energyrequiredtodisplacean 
electronfrom theKshellofthatspecificatom. Thisenergyischaracteristicofphotoelectric 
absorption as discussed above. The K-edge energy is usually slightly more than the 
binding energyoftheK-shellelectron sothattheincidentphotoncanbeabsorbed. 
Formaximum contrastbetweentissueandGd-enhancedareas, 
imagingshouldbeperformedateitherlow energiesorrightattheK-edgeofGd. 
LowenergyX-raysareusedto imagesoft tissues whereashighenergyX-rays(55-
70keV)areused toimagebone. Itiseasytodifferentiate between softtissue and bone but 
not soft tissue andmuscle. Atlowerenergies(15-25keV), greater contrast can be 
achieved because the NPswill partition into one ofthe two tissues and attenuate X-
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rays more than iodinated contrast agents. 
 
 
2- Biocompatible properties of nanoscale materials 
2-1 Multi functional nano systems for simultaneous medical diagnosis and 
treatment 
 It is highly desirable to develop novel methods that can achieve simultaneous 
in vivo imaging and treatment based on nanotechnology. For instance, ideally, while 
achieving simultaneous high spatial and temporal resolution of the lesions; special 
non-evasive treatments are implemented at the same time with various means, such 
as localized drug release and hyperthermia, in a controlled fashion.  
To achieve simultaneous imaging and treatment, like in vivo imaging-aided 
surgery, the critical challenges have been on the development of multifunctional 
nano systems with integrated capabilities. Such a nano system must be able to locally 
biomark cancer cells for efficaciously therapeutic treatment, through a process called 
“cell targeting” [6-7] . In this process, the nano system with multi functionalities, in a 
nanoparticle form, will be intravenously injected into the blood circulation at a very 
low dosage. Since these nanoparticles are surface functionalized with antibodies that 
are specific to cancer cells, they will selectively attach onto the cancer cells (they act 
as so-called bio markers or tags). The cell targeting is accomplished based on the 
antibody-antigen reaction that is tumor specific. 
Localized delivery of drugs into tumor lesions is also a key challenge for 
successful management of cancers. If designed correctly, one may achieve localized 
drug release in a highly controlled fashion. The controllability implies an externally 
installed wireless switch that can turn on and off the drug release process in the 
vicinity of the tumor. Nanoparticles with special structures and geometries may offer 
unique drug delivery capabilities [8-9] . These  nano-structured  materials  include  
hollow  nanospheres,  nanocapsules,  and  porous matrix systems which the drug is 
dispersed through. 
Suppression  of  cancer  cells  can  also  be  accomplished  by  magnetic  
hyperthermia without  drugs.  Magnetic  hyperthermia  is  associated  with  a  heating  
phenomenon  when magnetic nanoparticles such as Fe3O4 are placed in an alternating 
magnetic field [10-11] .  The magnetic hyperthermia mechanisms can be explained 
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by both hysteresis and relaxation losses, depending up on the characteristics of the 
nanomaterials [11] . For ferromagnetic nanoparticles, hysteresis loss counts for the 
area of the magnetization hysteresis curve. For nanoparticles that exhibit super 
paramagnetic properties, the so-called Neél Relaxation sets in due to fluctuation of 
the magnetic moment direction across an anisotropy barrier [11-12] . If the nano 
carriers are rendered magnetic, hyperthermia can be applied for cancer treatment. 
Upon arrival of the nanoparticles at the tumor sites via cell targeting, they will heat 
up locally to 41 ºC due to externally applied alternating magnetic field [13-14] . 
Above this temperature, the cancer cells can be effectively killed. The hyperthermia 
treatment does not involve any medicine, but only generates local heat at the cancer 
regions in a controlled fashion. 
By the establishment of the concepts of cell targeting and localized treatment 
based on nanotechnology, we are able to provide another important aspect in cancer 
diagnosis from the imaging perspective.  In  diagnosis and treatment of cancer, it is 
highly preferred  for the physicians to be able to observe the nano carriers for all 
times in a clinically convenient fashion. This will require the nanoparticles, by using 
the commercial in vivo imaging systems, to be observable due to their strong 
fluorescence in deep tissues. This is an important step in simultaneous diagnosis and 
treatment as the process can noninvasively take place at very early stage of cancer 
growth. 
 
2-1-1 The required property of nano particles for being biocompatible 
Numerous nanoscale systems have been developed recently in order to find efficient 
carrier systems for drugs that will facilitate their transport into specific tissues for 
minimizing deleterious side effects. The development of nanoparticles with multiple 
functionalities for in vivo imaging, drug delivery and targeted therapy is one of 
considerable challenges of nanotechnology in cancer diagnosis and treatment.  
 The key challenges in nanotechnology have been the design and development 
of a complex nano structure with integrated multiple functionalities. However, the 
material issues involved in the development of such nano assembly are often 
complicated by the interactions among different components. The required physical 
property, tuneability, biomedical versatility, and drug release controllability present 
even more challenges in both basic science study and engineering assembly process. 
First, the nanoparticle must be surface modified with specific functional groups for 
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the attachment of biological molecules. Second, for diagnosis, strong fluorescence 
from the nanoparticle is expected in the desired visible range for in vivo imaging. 
Third, magnetic hyperthermia has to be based on assembled nano system being super 
paramagnetic. Geometrical considerations of the nanoparticle would also be 
important for the storage and release of the anti cancer drugs. Finally, the 
nanoparticle should be highly biodegradable in order to reduce its toxicity. So far, 
few attempts have been made in the design  and  development  of  a  unique  
nanostructure  that  can  meet  all  the  requirements described above.For cell culture 
studies, a biocompatible particle must be nontoxic and inert, as well as stable over 
the course of an assay. 
 
2-2 Magnetic nanoparticles as drug carriers 
2-2-1Why magnetic nanoparticles 
Magnetic nanoparticles, composed of a magnetic (e.g. iron oxide/magnetite) 
core and a biocompatible polymeric shell (e.g. dextran, starch), offer a potential 
method for tumor drug delivery with benefits that extend beyond the "passive" EPR 
effect [16]. Several investigators have demonstrated that magnetic nanoparticles 
could be "actively" retained at  tumor  sites,  after  local  administration  combined 
with  a  locally  applied  external magnetic field, thereby enabling "active" magnetic 
targeting [17, 18]. Additionally, it has also been shown that detectable amounts of 
magnetic nanoparticles were able to reach brain   tumor    lesions    after   
intravascular    administration    [19,   20].   Moreover,    spatial distribution of  
magnetic    nanoparticles    within   various   organs   can  be  non-invasively 
visualized on   MRI   scans,   using   clinically    relevant   imaging    techniques    
[21,   22]. Furthermore,   the biocompatible   polymeric  shell of the nanoparticles   
can be employed  for encapsulation  or  attachment   of  both  low  molecular   
weight  drugs  and  macromolecules [23-25].  These  findings  lay the groundwork  
for investigation  of magnetic  nanoparticles  as a potential  MRI-visible   carrier  of 
macromolecular   therapeutics  to brain tumors. 
To  better   appreciate    the   requirements    from   magnetic   nanoparticles    
related   to  their potential  use  as MRI-visible   drug  carriers,  it is imperative  to 
understand   their  magnetic properties. 
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2-2-2Magnetic properties of nanoscale magnetic material 
First, it is useful  to define  what materials  are referred  to as "magnetic"   
with respect to the magnetic   targeting   application.   In  general,  magnetism   in  
materials   originates   from  the spin and  orbital  motions  of electrons  and the 
interactions  between  the  electrons.  To this regard,  all matter  is magnetic   [26].  
However,  from the  standpoint  of many  applications, the distinction  between  
"magnetic"   and "non-magnetic"   materials  is made  based on their response   to  
externally   applied   magnetic   fields.  The  property   defining  the  response  of 
magnetic  material  to  an external  field  is termed  'magnetic   susceptibility'    (x). 
Magnetic susceptibility    is  a  measure   of  the  ability   of  a  material   to  become   
magnetized   with magnetization   M in the presence  of an external  magnetic  field 
(H): 
Equation 1 
The magnetic  behavior   of materials  can be classified  into  5 major  groups:  
diamagnetic, paramagnetic,  antiferromagnetic,   ferromagnetic  and ferrimagnetic  
[26]. Diamagnetic, paramagnetic   and  antiferromagnetic    materials  exhibit  very 
weak  magnetic  susceptibility. For example,  typical  susceptibilities   of 
paramagnetic  materials  are on the order of~10-3to 10 -5 [27].   From  the standpoint  
of "magnetic  targeting"  these materials  can thereby  be referred  to as "non-
magnetic".    In contrast,  ferro- and ferrimagnetic  materials  exhibit high magnetic   
susceptibilities    on  the  order  of  50  to  10,000  (below  a  certain  temperature, 
known  as Curie temperature   (Tc)   [27], and thus can be termed  "magnetic". 
High magnetic   susceptibility   in ferro-/ferrimagnetic    materials  arises  as a 
consequence  of their   highly   ordered    spatial   arrangement    on   the   
interatomic    scale   [26,   27].   Both paramagnetic    and  ferro-/ferrimagnetic    
materials   contain  atoms  or  ions  with  permanent magnetic   moment   due  to  the  
presence   of unpaired  electrons  in partially   filled  orbitals. However,  a crystalline  
lattice in ferro-/ferrimagnetic   materials  dictates ordered atomic confinement   
allowing   strong  collective  interaction  between  the atomic  spins.  Such long­ 
range  interactions   are  absent  in paramagnetic   materials,   where  each  individual   
atomic spin   is  unaffected    by   its  neighbors.      The   long-range   interactions    
are  produced   by electronic   exchange   forces  and  result  in  a parallel  or  anti 
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parallel  alignment   of  atomic moments. 
On  the  nanoscale,    the   size  of  magnetic   particles   largely   determines   
their  magnetic properties.   It is useful  to clarify  the reference  to the term  "size".  
Magnetic  nanoparticles used  for biomedical   applications   frequently   constitute  a 
composite  where  particles  of a magnetic   component    are  coated  with  a  
polymeric   shell  [28].  The  overall   size  of  the composite,   defined  by  its  
hydrodynamic   diameter  will  be  different  from  the  size of its constituent   
magnetic   crystal,   which   is  mainly   responsible   for  the  magnetism   of  the 
composite.  Thus,  through  the rest of this section, the term  "size"  will be used to 
describe the particle  size of the magnetic  component. 
Below   a  critical   particle   size,   an  individual   magnetic   particle   
resembles   a  tiny  bar magnet,  magnetized   along  a preferred  direction  [29]. Such 
particle  is known  to consist of a single  magnetic  domain.  It was  estimated  that  
spherical  particles  of magnetite  (Fe3O4) would  comprise   a  single  magnetic   
domain  below  a  critical  diameter   of  128 nm  [28]. "Single  domain"  implies  
that the particle  is uniformly  magnetized  due to the alignment  of atomic  spins,  
which   act  cooperatively   and  produce   a net  magnetization.   
Energetically,favorable    alignment    of   the   magnetization    occurs   along   
a   specific   crystallographic direction,   known  as the  easy  axis  of the  material.    
Intrinsic  magnetic   alignment  due to crystalline    orientation    is   called   
magnetocrystalline     anisotropy.    Magnetic   anisotropy energy   (Ea),  associated  
with  magnetocrystalline  anisotropy,  keeps  a  single  domain particle magnetized in 
a particular direction. The anisotropy energy is proportional to the particle volume  
(V) [30]. As the particle size continues to decrease below the single domain value, 
the anisotropy energy is also decreasing. At a given temperature (T), there is yet 
another size threshold below which the anisotropy energy becomes sufficiently low 
so that the thermal activation energy, kbT with kb as the Boltzman constant, is able 
to overcome it and move the magnetization direction of the nanoparticle away from 
its easy axis, thus resulting in random flipping of the magnetization direction [31] 
This latter size limit  represents  a  transition  from  the  ferro-/ferrimagnetic  
behavior  to "superparamagnetic" behavior on the nanoscale. 
 The  nanoscale  effect  of  particle  size  on  magnetic  properties  can  be  
visualized  by monitoring the behavior of magnetic nanoparticles during the 
processes of magnetization with increasing external magnetic field, and 
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demagnetization with gradual decrease of the field (Figure  1) [27,  32, 33]. Prior to 
magnetic field exposure, a sample of single domain  magnetic  particles  constitutes  
an  assembly  of  randomly  directed  magnetic moments,  exhibiting  zero total 
magnetization.   An  applied magnetic field causes the magnetic  moments  to  align  
with  the  field  via  moment  and  particle  rotation.  The magnetization of the sample 
is increasing with the rising applied field until it reaches a plateau, known as 
saturation magnetization (Me),   Thesaturation magnetization is the maximum 
induced magnetic moment that can be obtained per given weight of magnetic 
material and it is reached  when all spins are aligned with the direction of the field. 
Beyond  the  field  corresponding  to  magnetic  saturation  (Hs)  no  further  increase  
in magnetization occurs. If the field is then gradually decreased from the Hs value, 
the spins tip out of alignment with the field and the total magnetization decreases. 
The pronounced differences between    the    larger    single    domain    particles    
and    the    smaller "superparamagnetic" particles   arise  during  this   
demagnetization  phase.  In  ferro­ Iferrimagnetic materials the demagnetization 
curve does not follow the profile of initial magnetization,   displaying   a hysteresis  
loop  (Figure  1, A).  When  the  applied  magnetic field  returns  to  zero  value,  the  
sample  still  retains  a residual  magnetic  moment,  called remanent  magnetization   
(MR).      In contrast,  in superparamagnetic   materials,  the demagnetization     
curve   completely    overlaps   with   the   magnetization    profile   and   no 
remanent    magnetization     is   observed    (Figure    1,  B).      For   example,   it  
has   been experimentally   demonstrated   that at physiologically   relevant  
temperature  of 300 K small particles    of   maghemite     (y-Fe2O3)   of   5-10   nm   
in   diameter    exhibited    overlaping magnetization     and    demagnetization     
profiles    with   no   remanent    magnetization,    in agreement  with 
superparamagnetic    behavior  [32]. In contrast,  larger particles  (>50 nm) of the 
same material  displayed  hysteresis and remanent magnetization,  characteristic  of 
ferrimagnetic  behavior  [32]. 
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Figure   1. Schematic  profiles  of magnetization   (M) versus  applied  magnetic  field (H) for (A) ferro-/ferrimagnetic    and 
(B) superparamagnetic   nanoparticles. MS and MR are the saturation  and the remanent  magnetization,   respectively.  HS is 
the applied  field at which  the saturation  magnetization   is achieved.  Arrows  depict the direction  of change  in magnetization   
with increasing  (arrow up) and decreasing  (arrow down) magnetic  field. 
 
The difference  in demagnetization   behavior between the ferro-
/ferrimagnetic   and superparamagnetic     materials    arises   from  their   different   
relaxation   kinetics   after  the removal  of an external  magnetic  field.  The 
randomization   of aligned  spins  can occur by physical   rotation   of  the  individual   
particles   suspended   in  the  liquid  medium   and  by fluctuations   in 
magnetization   direction  within  a particle,  occurring  by a coherent  rotation of all 
atomic  magnetic   moments  within  a particle  [33].  The  latter  effect,  also known  
as Neel  relaxation,   mostly  accounts  for the difference   in relaxation  time-scale  
between  the single  domain  ferromagnetic   and superparamagnetic   particles.   The 
Neel relaxation  of an assembly   of  aligned  uniaxial   single  domain  particles  
which  is first  fully  magnetized  to saturation  magnetization   M, is given by [31]: 
 
M = Ms                            Equation 2 
wheretisthetime afterremoval ofthefieldand'r istherelaxation 
timefortheprocess. Therelaxation timeisgivenby [31] :  
 
τ - 1  =  f o exp( -E a /K b T)  =  f o exp(-KV/k b T )          Equation3 
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where foisoften taken asaconstant of 109 sec-I,  E,isthe anisotropy  energy, 
Kisthe anisotropy energy perunitvolume, Visthevolume oftheparticle. 
Itisevident fromEquation  [3]thatrelaxation kinetics isgoverned byinterplay 
between the anisotropy  energy,  which  essentially  serves   as the energy   barrier  to 
prevent the change in direction  of magnetization,   and the thermal   energy. Due to 
the exponential dependence   oftherelaxation timeronparticle volume V,arelatively 
smalldifference in particle sizeonthenanoscale gives risetoaremarkable difference 
intherelaxation time. Forexample,   itwas estimated   that ataroom temperature  
aspherical ironparticle of23 nm in diameter  will have a  relaxation  time of 0.1 sec 
and hence will reach thermal equilibrium  almost instantaneously,  whileaparticle 
of30nmwillhavearelaxation time of109secandhence willretain astablemagnetization 
[31]. 
The superparamagnetic behavior is defined  as the ability  of magnetic  
articles  to undergo relaxation  with relaxation  time lower than the measurement  
tᵇime,  typically  assumed to be 't = 100 sec [31]. To achieve the relaxation time of 
100 sec, the energy barrier of the anisotropy energy KV should be equal to 25kbT. 
For a given particle, the temperature at which this condition is satisfied is called the 
"blocking temperature", Tb:   
Tb =KV/25Kb                                  Equation4 
Below Tb  the  anisotropy  blocks  the  free movement of the  magnetization 
within the particles [33]. In contrast, above Tb thermal activation is sufficient to 
overcome magnetic anisotropy  and the nanoparticles  become superparamagnetic. 
Thus, the particles will exhibit   superparamagnetic   behavior   in  the  physiological  
milieu   if  the  blocking temperature Tb is below the physiological temperature of 
310 K. It was experimentally demonstrated  that  for  the  monodispersed  
nanocrystalls  of  magnetite  (Fe3O4) and maghemite (γ-Fe2O3), the blocking 
temperature T, continuously increased with nanocrystal diameter from 40 K for 5 nm 
crystals to 260 K for 22 nm crystals [34]. Thus, magnetite and maghemite  particles 
as large as 22 nm in diameter would still exhibit superparamagnetic behavior under 
physiologically relevant conditions. 
For in vivo applications of magnetic nanoparticles, such as magnetic targeting 
and MRI imaging, superparamagnetic behavior is a property of paramount 
importance. Individual ferrimagnetic particles maintain intrinsic magnetization even 
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in the absence of external magnetic field [32]. Therefore, they will tend to 
agglomerate in solution due to magnetic attraction between the particles. In contrast, 
the magnetization of individual superparamagnetic  particles   fluctuates  randomly  
since  thermal  energy  is  able  to overcome the  anisotropy  barrier which keeps the 
particle magnetized in a particular direction. Consequently, superparamagnetic 
nanoparticles will not tend to aggregate due to interparticle magnetic attraction in the 
absence of magnetic field [32]. 
While  superparamagnetism    is an extremely  beneficial  property  for in 
vivo application,  it should   be  kept   in  mind   that   magnetic   nanoparticles    will   
exhibit   superparamagnetic behavior  only  below  certain  size threshold  [31]. 
However,  it has been demonstrated  that magnetic   properties   of  nanoscale   
magnetic   particles   become  weaker  with  reduction  in size  [35].  For  example,   
investigation   of  magnetic   properties   of  magnemite   (γFe203) nanoparticles   
revealed   that  saturation   magnetisation   decreased   linearly  with  decreasing 
crystallite   size  [35].  As  a  result,  small  superparamagnetic    nanoparticles   (e.g.  
AMI-25 iron oxide  nanoparticles   containing   crystals  of about  10 nm  in diameter  
[32] cannot  be withdrawn  from  solution  with the magnetic  fields and magnetic  
field gradients  emanating from the strongest  commercially   available  permanent  
magnets  in any time frame [32]. 
Is  it  possible   to   design   magnetic   nanoparticles    exhibiting    
superparamagnetism,     yet amenable  to manipulation   by external  magnetic  
fields?  To better  address  this question,  it is imperative  to understand   the 
processes  governing  retention  of magnetic  nanoparticles in  a  physiological    
milieu   by  external   magnetic   fields,  a  strategy  known   as  magnetic targeting. 
 
2-2-3 Magnetic targeting 
Magnetic  targeting  is a promising  strategy  for achieving  localized  drug 
delivery  to tumor tissue.   The accumulation   and retention  of drug-loaded  
magnetic  nanoparticles   in tumors can be enhanced   due  to magnetic  capture  of 
nanoparticles   within  the tumor  by external magnetic   field  applied  at the  tumor  
region  [16].  Several  studies  have  demonstrated   the feasibility  of magnetic  
targeting  in rodents  bearing  subcutaneous  tumors  [18,23,36].    In a typical  setup,  
magnetic   nanoparticles   are administered   intravascularly   and carried  by the 
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blood  flow into microvasculature    of the target tumor  tissue.  A source of magnetic  
field is positioned  directly  towards  the tumor  to capture  the particles.  
Conceptually,  the magnetic targeting   situation   in  an  individual   microvessel   is  
analogous   to  a magnetic   separation process,  where  magnetic   nanoparticles   are 
extracted  from their  carrier  fluid as they flow through  a region  of magnetic  field 
gradient  [37].  
Where Sm is referred to as magnetophoretic driving force and velocity Vx of 
particle can be derived from the balance of the magnetic and drag forces actingg on a 
paricle. 
Vx = SxM                                       Equation 5 
 
Thus,  according   to Equation   [5],  the  velocity  of the magnetically   
induced  movement of magnetic   nanoparticles    in a liquid  medium  of  density  
11µis determined   by two  main factors:  the magnetophoretic    driving  force  
created  by the magnetic  field gradient  and the magnetophoretic     mobility    of  the   
nanoparticles.    The  magnetophoretic    mobility   is  a measure  of how 
magnetically   movable  the particle  is in a given liquid and is analogous  to the  
electrophoretic    mobility   in  the  context  of  movement   under  electric  field  
gradient. Magnetophoretic     mobility    of   magnetic    nanoparticles     is   a   
property    of   paramount importance    with   respect    to   magnetic    targeting.    
To   successfully    entrap   magnetic nanoparticles   flowing  with  the  blood  in the  
microvessels   of target  tissue,  the movement of nanoparticles   towards   the  
highest  field  density  should  be  fast  enough  to  avoid  their escape   with   the  
flow   away   from  the  target   region.   Since  the  magnetically   induced velocity   
of  the  nanoparticles    is  directly  proportional   to  the  magnetophoretic    mobility 
(Equation  [5]),  theoretically,   higher  mobilities  should result  in a more efficient  
capture of magnetic  nanoparticles. 
 
 
 
 
2-2-4  Desirable  properties  of magnetic  nanoparticles  for magnetic targeting  
of brain tumors 
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Several properties  of magnetic nanoparticles are indispensible in order to 
successfully utilize these particles as magnetically targeted carriers for the delivery 
of drugs to brain tumor. 
First important  issue for in vivo applications is the material toxicity [38]. Magnetic 
targeting involves intravascular administration of the particles. Thus, even if the 
magnetic capture of the carrier at the target site is efficient, it would be hard to avoid 
systemic exposure to magnetic nanoparticles. Therefore, it is very important to 
guarantee that the nanoparticles are biocompatible and biodegradable and their 
metabolites are non-toxic and well tolerated by organs and systems ofthe body. 
Second desirable property for magnetic nanoparticles designated for 
physiological application  is  superparamagnetism  [22,  32]. As  was  mentioned  in  
Section  2-2-2, at temperature  well  above  Tb,  the  reversals of  a magnetic moment  
of  each individual particle by thermal energy are so rapid that in zero external field 
the time-averaged net moment on a particle is zero. The lack of a net magnetic 
moment in zero field reduces the tendency of  superparamagnetic  nanoparticles to  
aggregate due to  forces of magnetic attraction   outside   of   the   target   region.   
Uncontrolled   aggregation   of   magnetic nanoparticles would potentiate material 
toxicity as the aggregates might embolize the microvasculature and reduce the blood 
supply to vital organs. 
Third desirable property of nanoparticles is the ability to extravasate at the 
tumor site. Magnetically-retained superparamagnetic nanoparticles demagnetize 
upon removal of the magnetic  field  and  are  gradually  cleared  out  from the  target  
tissue.  The  ability to extravasate would  allow the nanoparticles to  remain 
embedded within the interstitial space of the tumor  lesion and slowly release the 
cytotoxic compounds in a localized fashion. Particle size and a vascular pathology of 
a given tumor determine the ability of the particles to traverse the vascular wall. The 
cut off of particle size for extravasation through  glioma  vasculature   was  
determined   to be  100nm  in an U87  high-grade   glioma intracranially   implanted  
in mice [15]. 
Finally,  to achieve  efficient   entrapment  of the magnetic  nanoparticles   by 
magnetic  field gradient,  it is essential  that the nanoparticles   exhibit high 
magnetophoretic   mobility. 
2-2-5 Biomaterials for magnetic targeting 
Magnetite  (Fe304)  and  maghemite  (y-Fe2O3) are  magnetic  materials  most  
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intensely researched  for  magnetic  targeting  applications.  These crystalline  iron 
oxides exhibit ferrimagnetic behavior.   Although some ferromagnetic transition 
metals (e.g. Ni, Co) inherently  display   higher   magnetic  response  that   
ferrimagnetic  iron  oxides,  the biomedical use of transition metals is greatly 
restricted due to high toxicity [33]. Conversely, the great advantage of ferrimagnetic 
magnetite and maghemite lies in their very  favorable  tolerability  profile  
demonstrated  in  both  animal  models  and clinical studies [17, 39, 40]. Indeed, 
animal studies with magnetite-containing nanoparticles labeled with 59Fe radiotracer 
revealed that, following liver metabolism, 59Fe could be found in normal pools of 
endogenous iron (e.g. hemoglobin) [40]. Moreover, no signs of acute toxicity was 
evident at doses up to 165 mg Fe/kg [40], while doses of only about 10-15 mg  Fe/kg  
were  shown  to  be  sufficient  to  produce  MRI-detectable  contrast enhancement of 
brain tumors [41]. 
Many strategies have been  employed for preparation of magnetite-based 
particles for drug delivery. These strategy most commonly involved two scenarios: 
1) coating a single small superparamagnetic crystal (or small polycrystalline 
aggregate) of magnetite with a biocompatible polymer (e.g. dextran) [42]; 2) 
embedding possibly aggregated pre-made magnetite cores within cross-linked 
polymeric or lipidic matrix [36, 43, 44]. 
Nanoparticles of the first type are widely used as contrast agents for MRI 
imaging. These particles contain  small superparamagnetic crystals of 4-7 nm 
diameter surrounded by dextran  coating,   resulting   in  a particle  with  
hydrodynamic   diameter  of  20-40  run  [45].   Due to their small size and thereby 
ability to extravasate at the tumor  site, these  monocrystalline particles  have  also 
been  studied as potential drug vehicles for passive tumor targeting [46].  However, 
in such capacity these particles do not offer considerable advantage in terms of tumor 
localization over non-magnetic colloidal carriers of similar size. This is because 
these agents are not amenable for active magnetic targeting, as they cannot be 
withdrawn from solutions with magnetic fields and magnetic field gradients achieved 
with the strongest commercially available permanent magnets [32].  The low 
magnetic responsiveness of these particles is likely to be due to the very small 
volume of their magnetic component that would result in extremely low 
magnetophoretic mobilities . 
Second strategy of particle preparation typically results in formation of 
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microspheres of relatively large size (0.5-2 urn) [36, 44]. Incorporation of several 
aggregated magnetite crystals into a particle increases the volume of magnetic 
component, thus contributing to higher  magnetophoretic  mobilities.  Indeed,  
capture  of  magnetic  microspheres by  an external magnetic field has been 
demonstrated in animal studies [36, 47]. However, the disadvantage of magnetic 
microspheres is their large size. Although microspheres might be useful for targeting 
certain extracerebral solid tumors which might be permeable to particles as large as 
1.2-2 urn [15], a more restrictive endothelial lining of brain tumors was previously 
shown to impede extravasation of particles larger than 100 run [15]. 
Although magnetic macro spheres are too large to comply with the carrier 
requirements for brain tumor targeting, they exhibit interesting morphology 
augmenting their magnetic responsiveness. This morphology can provide guidelines 
on design of particles optimized for targeting application. The core of magnetic 
microspheres may be composed of small magnetite crystals. When these small 
superparamagnetic crystals are individually coated with a polymer, the volume of the 
core is too small to be manipulated with external magnetic field. However, larger 
aggregates of superparamagnetic crystals seem to impart improved magnetization 
and, thus, improved interaction with the external magnetic field. 
Using    cores    of   aggregated     magnetite    crystal    it   might    be   
possible    to   improve magnetophoretic   mobility,  while retaining  
superparamagnetic   properties  of the material. 
A spherical  nanoparticle   of  100 nm diameter  can incorporate  up to 92 
superparamagnetic spherical   crystals   of  10 nm  diameter,   assuming   Keppler  
packing   density  of  74%  (i.e. maximal   volume   fraction   of  the  large  particle   
occupied   by  small   spheres   is  74%). The  magnetophoretic    mobility  of  a  100 
nm  nanoparticle densely   packed   with   10 nm  spherical   crystals  will  be  18 
times  higher  than  that  of  a typical   mono crystalline   nanoparticle,    composed   
of  a  single  spherical   core  of  10 nm diameter  and  exhibiting   a hydrodynamic   
diameter  of 20 nm.   This  calculation,  however, does not take into account  the 
magnetic  interaction  between  the individual  crystals within an aggregate.  
Intercrystal   magnetic  coupling  within  the aggregates  might  further augment the  
magnetophoretic     mobility   beyond   the  values   expected   for  an  ensemble   of  
non­ interacting  individual  crystals. 
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The   nanoparticles     of   100  nm   in  hydrodynamic    diameter,   which   
are   composed   of aggregated    superparamagnetic     crystals   of  magnetite   and   
coated   with   biocompatible polymers   seem  to  be  optimal   materials   for  brain  
tumor  targeting.   Such  nanoparticles would     be     non-toxic,      exhibit     
superparamagnetic      behavior,     yet    possess     high magnetophoretic    mobility   
and  also  have  the  ability  to  extravasate   through  brain  tumor vasculature.    
Thereby,    such   nanoparticles    seem  to  comply   with   all  the  requirements 
discussed   in  the  Section   2-2-4  to  serve  as  magnetically   targeted   drug  
carriers  to  brain tumors. 
In fact,  such  nanoparticles   have  already  been  developed   and  their  
usefulness  for tumor targeting  has  been  explored.   Alexious  et al. [23]  studied  
the  tumor  accumulation   of the described  magnetic  nanoparticles   radiolabeled  
with 59Fe with and without tumor exposure to  external  magnetic  field.  In these  
studies the  nanoparticles were  injected into the afferent artery supplying the 
subcutaneously implanted tumor in rabbits and the source of magnetic  field  was  
positioned  directly  towards  the  tumor  region.  33-fold  higher accumulation of 
magnetic nanoparticles was detected in the tumor of magnetically targeted  animals  
compared  to  the  non-targeted ones. Most  importantly, the particles exhibited very  
low toxicity,  as both histological and laboratory evaluation of animal organs and 
systems did not reveal significant signs of either acute or chronic alterations [17]. 
Although these studies illustrate great advantage of superparamagnetic aggregate­ 
based nanoparticles for magnetic targeting of subcutaneous tumors, the value of 
these particles for brain tumor targeting still remains to be determined. 
As it was mentioned in Section 2-2-1, the additional value of magnetic 
nanoparticles as drug carriers is their MRI visibility. This visibility can be explored 
to non-invasively monitor  the  distribution  of  the  carrier  in  vivo   in  a  clinically  
relevant  setting. To understand whether the  aforementioned morphology of 
magnetic nanoparticles would augment or impede their  MRI visibility compared to 
small monocrystalline particles, widely used as MRI contrast agents, it is useful to 
review basic concepts of MRI related to the mechanisms of contrast enhancement 
with iron-oxide based nanoparticles. 
successfully   killing   glioma   cells  in  culture  with  ICso  in the micromolar range, 
might become inadequate for combating brain tumor lesions in vivo. 
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To improve the outcomes of brain tumor chemotherapy, it is imperative to 
improve the therapeutic  index  through  reducing  systemic toxicity  and  increasing 
anti-tumor drug efficacy. Thus, therapeutic agents with higher tumor specificity and 
higher potency need to be designed. 
 
 
 
 
 
 
 
 
 
  
 26 
 
  
 27 
3- Materials and methods 
The following chemicals wereobtainedfrom bereket kimya(Istanbul,Turkey): 
FeCl3•6H2O, FeCl2•4H2O,Ba(NO3)2, Y(NO3)3•6H2O andamunyakacid(NH3). 
3-1 Matherial synthesis 
3-1-1 Synthesis of BaFe12O19nanoparticles 
Nowadays, nanostructured magnetic materials have been intensively 
investigated due to their applications in magnetic recording media, sensors and 
bimolecular separations. In particular, the barium hexaferrite (BaFe12O19) 
nanostructures has aroused great interest in the magnetic material field because of its 
important properties, such as large magneto crystalline anisotropy, high Curie 
temperature, moderate hard magnetic properties and high chemical stability . 
Asolutionof 1.2gofBa(NO3)2in100mLofdistilledwaterwaspreparedina100mL 
roundbottomflask and under continues stirring and warming up the solution to 40 
centigrade degrees. On the other side we added FeCl2 .4H2O and FeCl3.6H2O 
seperately to 100 mL of distilledwaterwaspreparedina100mL roundbottomflask and 
under continues stirring and warming up the solution to 40 centigrade degrees. These 
three solution were added to 600 mL of NH3 acid under fast stirring and 
simultaniously. The solution were heated up to 80 centigrate degrees within an hour. 
After appereance of black suspended particles, the solution were cooled to room 
temperature and waited for segregation and deperation due to magnetic property. 
ThepHofthesolution were measured about 10verifiedwithpHindicator strips. 
We decreased pH up to 7 by washing the solutionby magnet and dehydrate water. 
This pH is proper for seperating precipitated black particles through filter papers. 
After seperating particles by membraine, heated them in oven to 80 degrees 
instead of vaporising water and volatile materials from them. The particles after 
staing for 24 hours in oven, floured and prepered them for heating in four different 
temperature. The goal of this heating  will be described in XRD section in details but 
as a brief information this process has as the same gole as anealing proccess in steels. 
By heating them the noises which are originated from different impurities eliminated 
because of desappearing of  the impurities during heating. 
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Figure 3.1 :Aflowchartofthesynthesis of BaFe12O19 asdescribedabovebutin termsofmolaramounts ofthereagentsused and the 
sequenceoftheir addition. 
 
Figure 1 is a schematic steps of synthesize process for BaFe12O19 in liberator. 
NH3 is used for PH increasing of the solution and interaction of materials. Increasing 
PH of the solution can be done by other materials like adding NaOH to the solution 
but after aggregation of nano particles ,for separation of the particles from the 
solution by paperfilter,we faced problem because the increased PH by NaOH, 
decreases too hard and at the same time it gives some unwanted additional materials 
as impurities to the solution .The increased PH by NH3 decreases easily just by 
washing the solution by dehydrate water for several times. The produced particles 
have so powerful magnet properties so it can be easily recovered while it is washed 
by water. Figure 2 showes experiment in the order of step photos. 
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(a) adding FeCl2.4H2O to 150 mlitdehydratewater 
 
(b) adding FeCl3.6H2O to 150 mlit dehydrate 
 water 
  
(c)Simultaniously adding of solutions to NH3 and Ba(NO3)2 (d)Heating and stirring for an hour of solution 
 
Figure 3.2 : Synthesis of nano particles in step of photos 
 
The amount of dehydrate water is changed in three steps, for obtaining 
different particle sizes. SEM pictures of products show size decrease of particles.  
Figure 2 (a) is adding of FeCl2.4H2O to 150 mL of dehydrate water with 
heating the solution up to 40 degrees. Increasing of temperature helps homogeneous 
solving of elements in water at the same time stirring of this solution boost its 
homogeneous structure in solution.Thestirring stick is made in laboratory and the 
material used for itis Teflon because produced nano particles are magnet and can be 
 30 
affected easilyduring the production if they are stirred by conventional stirring 
machines. In Figure 2 (b) other solution prepared for adding to the process (adding of 
FeCl3.6H2O to water). In Figure 2 (c) two prepared solutions added to NH3and 
Ba(NO3)2under continues stirring and heat increasement. The amount of NH3in (c) is 
double of the amount of dehydrate water used in (a) and (b). The color ofNH3 
solution is changed to black after addition of (a) and (b) and .B y constant stirring 
and heat increase black nano particles gave birth in the basher. 
 
 
 
Figure 3.3: Magnetic property of produced nano particles 
 
In Figure 3 black aggregated BaFe12O19 particles are shown while washing 
with dehydrate water. As it can be seen from the picture, magnetic nano particles are 
precipitate at the bottom of the solution because of magnetic field objected to the 
basher. Magnetic properties of these nano particles can be used as contrast agent in 
cancer cell detection. 
 
3-1-2 Synthesis of Y3Fe5O12nano particles 
Yttrium iron (Y3Fe5O12) has been widely used as a permanent magnetic 
material because it has the following advantages: the manufacturing cost is low; its 
properties are stable; and the problem of oxidation of the product is avoided. The 
properties of this magnetic material are related to purity, size, and morphology of the 
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precursor powder. By modifying its microstructure and by controlling its chemical 
composition, size and morphology, its properties can be improved. Therefore, the 
preparation of nano- Y3Fe5O12 having high purity, ultrafine size, good dispersion and 
excellent magnetism has been the focus of recent research.  
Synthesis of Y3Fe5O12 is in the same method with previous process used in 
BaFe12O19. Just like other two solutions, amount of water were changed in the three 
steps for changing in the size of the nano particles. On the next section SEM pictures 
will say the fact of decreasing in size by making the solvent in double or triple 
amount. In figure 4 step vise schema of the process is shown. 
Asolutionof 7.7grofY(NO3)3 .6H2O 
in100mLofdistilledwaterwaspreparedina100mL roundbottomflask and under 
continues stirring and warming up the solution to 40 centigrade degrees. On the other 
side we added FeCl2 .4H2O and FeCl3.6H2O seperately to 100 mL of 
distilledwaterwaspreparedina100mL roundbottomflask and under continues stirring 
and warming up the solution to 40 centigrade degrees. These three solution were 
added to 600 mL of NH3 acid under fast stirring and simultaniously. The solution 
were heated up to 80 centigrate degrees within an hour. After appereance of black 
suspended particles, the solution were cooled to room temperature and waited for 
segregation and deperation due to magnetic property. 
 
Figure 3.4 :Aflowchartofthesynthesis of Y3Fe5O12 NPs asdescribedabovebutin termsofmolaramounts ofthereagentsused and the 
sequenceoftheir addition. 
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3-2 Scattering electron microscopy (SEM)  
As it is mentioned in material synthesis section we solved initial material in 
100 ml dehydrate water before adding them to NH3. We repeat synthesising barium 
ferrit and yittirium ferrit 3 times by 3 different amount of dehydrate water for 
comparing the produced nanoparticle sizes in each solution. 
We used 300 ml, 800 ml and 1200 ml dehydrate water.A NP sample of 
approximately 1-2 mg was dispersed in 5 mL of water and a drop of this mixture was 
evaporated on Silicon wafer.  Samples in powder form were sent to the Tekstile 
Engineering lab where SEM was performed. 
 
3-3 X-ray diffraction 
X-ray scattering techniques are a family of non-destructive analytical 
techniques which reveal information about the crystal structure, chemical 
composition, and physical properties of materials and thin films. These techniques 
are based on observing the scatteredintensity of an X-ray beam hitting a sample as a 
function of incident and scattered angle, polarization, and wavelength or energy. 
Note that X-ray scattering is different from X-ray diffraction, which is widely used 
for X-ray crystallography. 
Elastic scattering: Materials that do not have long range order may also be 
studied by scattering methods that rely on elastic scattering of monochromatic X-
rays. 
Small-angle X-ray scattering(SAXS) probes structure in the nanometer to 
micrometer range by measuring scattering intensity at scattering angles 2θ close to 
0°. 
X-ray reflectivity is an analytical technique for determining thickness, 
roughness, and density of single layer and multilayer thin films. 
Wide-angle X-ray scattering (WAXS), a technique concentrating on 
scattering angles 2θ larger than 5°. 
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Inelastic scattering: When the energy and angle of the inelastically scattered 
X-rays are monitored, scattering techniques can be used to probe the electronic band 
structure of materials. Inelastic scattering alters the phase of the diffracted x-rays, 
and as a result does not produce useful data for x-ray diffraction. Rather, inelastically 
scattered x-rays contribute to the background noise in a diffraction pattern. 
 Compton scattering 
 Resonant inelastic X-ray scattering (RIXS) 
 X-ray Raman scattering 
 
 
Figure 3.5 : using hydraulic press and particles sample produced in right for placing in to the oven 
 
Figure 5 shows the instrument for preparing powder in backing process. 
During backing process argon gaz (Ar) were flowed in to the oven for preventing 
nano particles interact with oxygen of the air and cause their burning. Although 
flowing pressure of Ar in the oven was so less, we should capsulate our produced 
powders in order to prevent them to carried by flowed up Ar gas and reduced 
probability of burning with air inside the oven. Figure7 (c) shows the blue tube for 
pumping Ar gas in the oven while backing in 1100 degrees. 
 
 
 
Figure 3.6 : capsulation of the nano particles, backing them in oven in different temperature. 
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After shaping powders with hydraulic pressure instrument, capsulated 
particles were placed in tube for backing in three temperatures. As  mentioned before 
from each kinds of nano particles three different sample were prepared for backing 
step, so we repeat this step 9 times for three nano particle in three various 
temperature. Figure 7 (a) (b) (c) are demonstrating step temperature in annealing 
nano particles. 
  
(a) (b) 
 
(c) 
Figure 3.7 : backing process of nano particles in order to reduce the noises in X-Ray Scattering 
 
Just as shown in Figure 6, nano particles are capsulated in hydraulic press and 
placed in oven for heating them. There were three types of particles from three types 
of particles and in total 9 experimentsdone for backing nano particles process and 
from each of the samples X-Ray scattering took. 
After backing capsules they became stiff therefore we should mill them well 
for the next step, putting in the X-Ray scattering instrument.  
X-rays are electromagnetic radiation similar gamma-rays. They are produced when 
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electrically charged particles of sufficient energy are decelerated. In an X-ray tube, 
the high voltage maintained across the electrodes draws electrons toward a metal 
anode. X-rays are produced at the point of impact and radiate in all directions.  
If an incident X-ray beam encounters a crystal lattice, general scattering 
occurs. Although most scattering interferes with itself and is eliminating, diffraction 
occurs when scattering in a certain direction is in phase with scattered rays from 
other atomic planes. Under this condition the reflections combine to form new 
enhanced wave fronts that mutually reinforce each other.  
X-ray diffraction data from polymers provide information about crystalline, 
crystallite size and orientation of the crystallites. This technique can be used to 
characterize polymer-layered silicate nanocomposite. By monitoring the position, 
shape and intensity of the basal reflections from the distributed silicate layers, the 
nanocomposite structure may be identified.  
 
 
 
Figure 3.8 : .X-Ray Diffraction instrument. 
 
Figure 8 shows X-Ray diffraction machine with its two hand one for sending 
X-Ray and the other for receiving extracted X-Rays from structure of material. 
Degrees of inspection in the experiment were adjusted between 19 and 70 degrees 
and duration of each test was about 5 min. 
Nano particles in three different categories were scanned by this instrument. 
Powdering of nano particles should be done just like flour otherwise X-Ray scanning 
will be with lots of noises inside and it can direct us to different information. After 
producing nano particles, they were backed in oven with three different degrees. In 
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continues changing of these X-Ray diffractions with increasing of backing 
temperature will be shown and great difference between them will become obvious. 
 
 
 
Figure 3.9 : milling nano particleswell up to powder situation (flour) 
 
In our method, particles should mill up to flour powder phase. To determining 
the structure of particles with scattered X rays powdering should be done well 
because each degree of scattering shows information about materials inside the 
structure of particles. 
 
After milling nano particles as shown in Figure 9, samples placed in specific 
glass like lam section of the instrument with its unique shape. Figure 10 shows 
geometry of glassy lam of scattering instrument with a half circle in the middle. This 
circle somehow is for gathering particles in the middle of lam and making condense 
concentration of particles exactly in the way of X-Ray emitting. 
 37 
 
Figure 3.10 : shape of specific lam of scattering X-Ray machine 
 
3-4 Magnetic field experiments 
Experimental investigations of the application of magnetic materials for 
hyperthermia date back to 1957 when Gilchrist et al. heated various tissue samples 
with 20–100 nm size particles of γ-Fe2O3 exposed to a 1.2 MHz magnetic field. 
Since then, there have been numerous publications describing a variety of schemes 
using different types of magnetic materials, different field strengths and frequencies, 
and different methods of encapsulation and delivery of the particles . 
These studies experimentally prove the high efficiency of a 
superparamagnetic crystal suspension to absorb the energy of an alternating magnetic 
field and convert it into heat. Given that tumor cells are more sensitive to a 
temperature increase than healthy ones ,this property can be used in vivo to increase 
the temperature of tumor tissue and to destroy the pathological cells by hyperthermia. 
Many efforts have been devoted in the last 20 years to improve hyperthermia 
techniques for clinical applications. Advances in the area of nanotechnology have 
contributed to the development of magnetic fluid hyperthermia. This technique is a 
promising technique for cancer treatment because of ease in targeting the cancerous 
tissue and hence having fewer side effects than chemotherapy and radiotherapy. It is 
notable that the results of current/ongoing clinical trials show significant reduction in 
side effects . 
Our produced particles are plan to use in vitro. Inside body within blood 
phase, these particles should be activated by magnetic field even while using in vitro. 
For examine this effect in a phase so close to blood phase, we decided to mix our 
particles in agar-agar gel and face it in magnetic field, for evaluating their effect in 
this situation. 
We made a solution of 0.5 gr agar powder solved in 50 ml hot water via water 
bath method.Then we strew 0.1 ,0.5 and 1 gr of BaFe12O19 in seprated test tubes and 
pure 1.5 ml of agar solution to each tube and let the solutions to cool down to room 
temperature. All these samples are took to evaluate in magnetic with by SAYKON 
Indection High Frequency Heat Producer with external power of 5 kW and external 
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velocity of 1-5 kHz in laboratory as it is shown in Figure 11. The solution of nano 
particles powder mixed in agar agar gell are placed in the test tube and it’s 
temperature before placing in magnetic field are took with laser point  temperature 
detector. 
 
 
 
Figure 3.11 :  Nano powder in agar gel in Indection high frequency heat producer 
 
As it mentiond before we made a solution of 0.5 gr agar powder solved in 50 
ml hot water via water bath method .Then we strew 0.1 ,0.5 and 1 gr of Y3Fe5O12 in 
seprated test tubes and pure 1.5 ml of agar solution to each tube and let the solutions 
to cool down to room temperature. All these samples are took to evaluate in magnetic 
with by SAYKON Indection High Frequency Heat Producer with external power of 
5 kW and external velocity of 1-5 kHz in laboratory. The solution of nano particles 
powder mixed in agar agar gell as shown in picture1 are placed in the test tube and 
it’s temperature before placing in magnetic field are took with laser point  
temperature detector. 
 
3-5 Magnetic resonance imaging (MRI) experiments 
In the next step we will go one step further for more real experience which is 
evaluating our produced particles in MRI with more real exam. In the next section, 
nano particles injected in a meat tissue and placed in MRI and CT machine in the 
Lutfi Kirdar Egitim ve Arastirma Hastanesi. With the help of doctor Mustafa Ozates 
chair man of Radiology Section in mentioned hospital, all the appointment were did 
with his help and we could do our tests in the hospital experimentally. 
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As it is shown in Figure 12, meat tissue with 10 centimeter thickness took as 
body presenter in our experiments. For first experiment we inject Y3Fe5O12, 
BaFe12O19 and Fe3O4 to the meat tissue (as it is in figure 4) in accurate orders. There 
are ordinary contrast agents used in MRI experiment we want to evaluate our 
produced materials in MRI instrument in the same situation. 
 
Figure 3.12 : Meat tissue meshed for injection of nano particles before MRI Experiment 
 
Figure 13, shows MRI machine in Lutfi Hospital. We place meat tissue in MRI and 
evaluate videos as the results. 
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Figure 3.13 : MRI instrument 
 
3-6Computed tomography (CT)  
X-ray computed tomography, also computed tomography (CT scan) 
or computed axial tomography (CAT scan), is a medical imaging procedure that 
utilizes computer-processed X-rays to produce topographic or 'slices' of specific 
areas of the body. These cross-sectional images are used for diagnostic and 
therapeutic purposes in various medical disciplines.Digital geometry processing is 
used to generate a three-dimensional image of the inside of an object from a large 
series of two-dimensional X-ray images taken around a single axis of rotation. In 
Figure 14 (b), schematic of BT machine showed and meat tissue placed in the center 
of BT machine (Figure 14 a). 
  
(a) (b) 
 
Figure 3.14 :  Meat tissue in the center of CT instrument 
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4- Experiments 
4-1 Scattering electron microscopy (SEM)  
Figure 1 shows the SEM micrographs of BaFe12O19 powders synthesized by 
the precipitation method . It can be seen from the graphs that the powders 
synthesized in 1200 ml dehydrate water are the smallest particles in size if we 
compare with the one made in 300 or 800 ml dehydrate water ; however, the powders 
annealed at 900 looks sticking to eachother .The average particles size as it is 
obvious in the figure is between 20-30 nano meters. 
 
 
 
Figure 4.1 :  Figures number 1,2 and 3 shows the SEM micrographs of BaFe12O19  powders synthesized by precipitation 
method at different amount of dehydrate water and figure 4 shows SEM micrographs of BaFe12O19  powders which are baked in 
900 degrees. 
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Figure 2 shows the SEM micrographs of Y3Fe5O12  powders synthesized by 
the precipitation method at . It can be seen from the graphs that the powders 
synthesized in 1200 ml dehydrate water are the smallest particles in size if we 
compare with the one made in 300 or 800 ml dehydrate water ; however, the powders 
annealed at 900 looks sticking to eachother . 
 
 
 
 
Figure 4.2 :  Figures number 1,2 and 3 shows the SEM micrographs of Y3Fe5O12 powders synthesized by precipitation 
method at different amount of dehydrate water and figure 4 shows SEM micrographs of Y3Fe5O12  powders which are baked 
in 900 degrees. 
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4-2 X-ray diffraction 
Steps of heat backing were done in minimum 4 steps. Although they were 
time consuming, effect of this process on decreasing noises on X-Ray scattering are 
shown for each of the particles but in different annealing temperature. Distinguishing 
of noise decrease and more focused X-Ray in the schema of each particle are 
obvious. 
 
  
 
Figure 4.3 :  shows the XRD patterns at room temperature for aligned BaFe12O19 powders sintered at 300, 500, 700 and 
900 °C, respectively. 
Figur 3 shows the XRD patterns at room temperature for aligned BaFe12O19 powders 
sintered at 300, 500, 700and 900 °C, respectively.  
Barium ferrite BaFe12O19 with hexagonal structure is widely used for 
permanent magnets, magnetic recording media and microwave absorbers, owing to 
its high stability, excellent highfrequency response, large magnetocrystalline 
anisotropy, and large magnetization as well.  
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As can be seen from the bottom curve, all peaks of the aligned powders 
sintered at 900 °C can be indexed as hexagonal BaFe12O19 phase.  
In order to achieve highly homogeneous ultrafine particles of barium 
hexaferrite, various techniques such as chemical coprecipitation, hydrothermal , sol–
gel, glass crystallization  and salt melt methods have been developed. The most 
important feature of these methods is the intimate mixing of the starting materials on 
an ionic level, so that the subsequent crystallization can occur at relatively low 
temperatures, leading to small particles. However, there are still a number of 
difficulties in obtaining pure, ultra-fine and homogeneous particles of barium 
hexaferrite with narrow size distribution as pointed out by several investigators.Here 
we used the milling process .In our method, particles should mill up to flour powder 
phase and after annealing in 4 different temperatures obvious X-ray pattern of       
BaFe12O19 is obtained . 
 
 
Figure 4.4 :  shows the accepted XRD patterns for aligned BaFe12O19 powders sintered at 900 °C 
 
Figure4. shows the accepted XRD patterns for aligned BaFe12O19 powders sintered 
at 900°C . 
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Figure 4.5 :  shows the XRD patterns at room temperature for aligned Y3Fe5O12  powders sintered at 300, 500, 700, 900 °C, 
respectively. 
 
In order to confirm the structure of the powder, it was annealed at 
temperatures where structure wasfoundaccordingwith DTA studies (Figure 4): 300, 
500, 700 and 900 C; theresultsareshowed in Figure 5. 
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Figure 4.6 :  shows the accepted XRD patterns for aligned Y3Fe5O12 powders sintered at 900 °C 
 
Figure6. Shows the accepted XRD patterns for aligned Y3Fe5O12 powders sintered 
at 900°C . 
 
4-3 Magnetic field experiments 
As it is shown in Figure 7 before placing the solution into magnetic field, its 
temperature is equal to room temperature and 19 degrees. While body placed in MRI 
machine for imaging by magnetic resonance dose not affected by magnetic field, so 
we should evaluate them in a condition close to body situation. Agar gel solution is 
usually take as blood solution in investigations and papers.  
As it is obviuos in Figure 8 the temprature of the nano powders in agar gel 
goes up under effect of the magnetic field . 
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Figure 4.7 : Nano powder’s temperature in agar gel befor placing in magnet field 
 
 
 
Figure 4.8 :   Temperature of 43.1 degrees belongs to nano powders of Y3Fe5O12  under effect of magnetic field 
 
Time duration of placing the solution in magnetic field was variable between 
10 seconds to 100 seconds .Each sample –containing variable doses of 0.1 , 0,5 and 1 
of  BaFe12O19–tested in 5 different kHzs and the test tube left in the mechine for 
10,20,50 and 100 seconds respectively. It means for BaFe12O19 ,60 tests done. 
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Figure 4.9 :  temprature increasing of  BaFe12O19 under effec of magnetic field in three different mass volume 
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As its obviuos in Figure 9 in all semples by increaing the frequency from 1 to 
5 and powder doze from 0.1 to 1 gr ,  temprature increases. The maximum 
temprature we reached in BaFe12O19 samples is 34.5 degrees and reached in 5 KHz 
and 1gr dose in 100 seconds. 
Figure 9, shows temperature increasing effected by magnetic field up to 34.5 
centigrade degrees. As mentions before within only almost 100 seconds the 
temperature increased to 34.5 degrees.  
We did the same test with Y3Fe5O12powders and we reached incredible 
results. 
As it is shown in figure 7, before placing the solution into magnetic field, its 
temperature is equal to room temperature and 19 degrees. Time duration of placing 
the solution in magnetic field was variable between 10 seconds to 100 seconds .Each 
sample –containing variable doses of 0.1 , 0.5 and 1 gr of  Y3Fe5O12–tested in 5 
different KHzs and the test tube left in the mechine for 10,20,50 and 100 seconds 
respectively. It means for Y3Fe5O12 ,60 tests done. 
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Figure 4.10 :  temprature increasing of  Y3Fe5O12 under effec of magnetic field in three different mass volume 
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As its obviuos in Figure 10 in all semples by increaing the frequency from 1 
to 5 and powder doze from 0.1 to 1 gr,  temprature increases. The maximum 
temprature we reached in Y3Fe5O12 samples is 44 degrees and reached in 5 KHz and 
1 gr dose. 
figure 10, shows temperature increasing effected by magnetic field up to 44 
centigrade degrees. As mentions before within only almost 100 seconds the 
temperature increased to 44 degrees which is a positive sign for the next step. If this 
solution is affected under magnetic field so we wish it will also effected by MRI 
experience. 
These nanosystems can be made to heat up, which leads to their use as 
hyperthermia agents, delivering toxic amounts of thermal energy to tumors, or as 
chemotherapy and radiotherapy enhancement agents, where a moderate degree of 
tissue warming results in more effective cell destruction . The increasing interest for 
MNP is due to the discovery of their physical and chemical properties.  
Our desired temprature is above 37, because normal human body temperature 
is 37°C we need toxic amounts of thermal energy to give to tumor cells for 
distruction because tissue warming results in more effective cell destruction.The 
maximum temprature we reached by barium ferrit is 34.5 that is seen in samples 
containing 1 gr of barium ferrit in 5 kw during 100 seconds being under effect of 
magnetic field.When we did the test by yitriyom ferrit we took better results ,we 
reached our desired temprature even in 2kw during 100 second (39.2)and temprature 
reached to 44 at 5kw during 100 second. 
We repeat the tests with unbaked particles as well and we reached incredible 
results.As its obvious from diyagrams in the samples containing 0.5gr of yitrium 
ferrit in 3kw during 50 seconds we reached 40.4 and with the same doze in 5kw 
temprature reached 60. We couldnot continue our tests by 1gr of solution because the 
test tube blown out and exploded as you see in the picture because temprature 
reached 80 in early stages of the test as it is shown in Figure 11. 
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Figure 4.11 :The unbaked particles inside the test tube under effect of magnetic field that exploded in 80 degrees 
 
 
4-4 Magnetic resonance imaging (MRI) experiments 
Results are shown in Figure 12 from both front and side view of tissue. White 
areas in the picture are our particles take role as powerful contrast agent. According 
to the MRI machine technician, our contrast agent even destroys view quality of 
pictures and in one picture which ordinary contrast agent are not obvious, our nano 
particles are shown accurate in the pictures 
 
 
 
(a) (b) 
 
 
Figure 4.12 :  High contrast of our material in MRI pictures (front and side view) 
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4-5 Computed tomography (CT)  
Figure 13 is one of the best pictures which we can take during the 
experiment, X-Rays are exactly tanganted to nile of injection area therefore three line 
of contrast agent are obvious in CT figure. 
 
 
Figure 4.13 :  CT image of meat tissue. 
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5- Conclusion and Future Perspectives 
WeobviousedthatourproducedMNPsexibitgoodability as 
contrastagentsandgoodhyperthermiaproperty in magneticfield invitro, sowe can 
hopefullyconcludethatthey can be used in vivoexperiments as well.Forusing in 
vivotheseparticlesshould be coatedbyspecialmaterialto be 
biocompatiblebecausetheseparticleseasily can be targetedbyantibodies . 
foravoidingthat,specialstealthMNPs can be designedthat can not be 
effectedbyantibodiesorsomeunticanceragents can be 
attachedtotheseparticlesforchemotherapy,this is a veryinterestingthatweattachfood on 
onearm of theproducednanoparticlesand a cancer killer agent on theotherarm. 
Sothetumorcellaccepts it liketheTorsionhorseintoitswallsthinking as 
foodbeforeinforming of thekillingagentandconsequentlythetumorcellwill be killed. 
 Theproducednanoparticles can be applied in dentistryalso. Forinstanceone of 
theblindspots of theconventionalamalgamsthat is used in dentistrydepartmentnowadays 
is thestickingwithdelay of the amalgam totheteethandpatiant has towaitfor amalgam 
tobecomestiffwhich is exhausting .Ifsmallamount of theproducedMNPsmixedwith 
amalgam ,it could be 
possibletoexposethepatianttomagneticfieldforshorttermjustafterfillingtheteethand it could 
be sticktoteethquickly. 
 Not onlytheproducednanoparticles can be used in biologicalaims but alsothey can be 
applied in industrialpurposes ,sincetheseparticlesexibitgoodhyperthermiaproperties in 
magneticfield ,they can be mixedwithspesificpolymerbasedmaterials as a 
weldagentwithoutapplyinganyexternalheatsourcetosoldertheseparatepieces, 
justbyexposingthemtomagneticfieldunderpressure.Thiskind of welding can be required 
in interiorparts of mechanismswhichareout of reach of 
engineerstosolderwithconventionalweldingtools. 
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